China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
1.700
+0.040 (2.41%)
At close: Dec 5, 2025, 4:00 PM EST
1.700
0.00 (0.00%)
After-hours: Dec 5, 2025, 8:00 PM EST

China Pharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
94452319
Upgrade
Market Cap Growth
137.15%12.27%-19.49%-78.32%17.59%88.26%
Upgrade
Enterprise Value
1288133026
Upgrade
Last Close Price
1.662.336.0547.95241.30222.90
Upgrade
PS Ratio
1.300.990.570.612.371.79
Upgrade
PB Ratio
1.000.580.541.153.802.43
Upgrade
P/TBV Ratio
-4.250.952.003.892.48
Upgrade
P/FCF Ratio
53.33-----
Upgrade
P/OCF Ratio
35.51-----
Upgrade
EV/Sales Ratio
2.871.721.141.603.102.42
Upgrade
EV/EBITDA Ratio
--4370.46-131.65259.95
Upgrade
EV/FCF Ratio
74.44-----
Upgrade
Debt / Equity Ratio
0.430.460.622.042.080.93
Upgrade
Debt / EBITDA Ratio
--58.59-39.1037.57
Upgrade
Debt / FCF Ratio
22.82-----
Upgrade
Asset Turnover
0.280.290.410.400.440.50
Upgrade
Inventory Turnover
2.152.172.052.552.642.44
Upgrade
Quick Ratio
0.080.180.310.200.530.13
Upgrade
Current Ratio
0.350.650.880.470.870.47
Upgrade
Return on Equity (ROE)
-42.98%-62.31%-52.43%-77.08%-48.49%-33.25%
Upgrade
Return on Assets (ROA)
-13.17%-18.29%-10.04%-10.97%-8.17%-7.43%
Upgrade
Return on Capital (ROIC)
-17.19%-24.48%-13.69%-14.06%-10.54%-10.30%
Upgrade
Return on Capital Employed (ROCE)
-33.60%-46.50%-28.50%-70.40%-23.60%-26.50%
Upgrade
Earnings Yield
-38.26%-105.81%-77.22%-80.22%-14.88%-14.76%
Upgrade
FCF Yield
1.88%-11.28%-17.84%-16.39%-3.01%-4.68%
Upgrade
Buyback Yield / Dilution
-135.14%-416.13%-221.82%-13.96%-5.75%-0.10%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.